Screening commercial available resins for simultaneous removal of two potential genotoxins from API methanolic streams

References

• Teasdale, A. (2010) Genotoxic Impurities: Strategies for Identification and Control, John Wiley & Sons: New Jersey.
   Google Scholar
• Zhou, L.; Mao, B.; Reamer, R.; Novak, T.; Ge, Z. (2007) Impurity profile tracking for active pharmaceutical ingredients: case reports. Journal of Pharmaceutical and Biomedical Analysis, 44: 421–429. doi:10.1016/j.jpba.2006.11.004
   PubMed Web of Science ®Google Scholar
• Teasdale, A.; Elder, D.; Chang, S.-J.; Wang, S.; Thompson, R.; Benz, N.; Flores, I.H.S. (2013) Risk assessment of genotoxic impurities in new chemical entities: strategies to demonstrate control. Organic Process Research & Development, 17: 221−230. doi:10.1021/op300268u
   Web of Science ®Google Scholar
• Snodin, D. (2017) ICH Guideline M7 on mutagenic impurities in pharmaceuticals, Vol. 14, Nº 3; b) Guidance for Industry Genotoxic and Carcinogenic Impurities in Drug Substances and Products: Recommended Approaches; U.S. Department of Health and Human Services; Food and Drug Administration; Center for Drug Evaluation and Research (CDER); December 2008.
   Google Scholar
• Szekely, G.; Sousa, M.C.A.; Gil, M.; Ferreira, F.C.; Heggie, W. (2015) Genotoxic impurities in pharmaceutical manufacturing: sources, regulations, and mitigation. Chemical Reviews, 16: 8182–8229. doi:10.1021/cr300095f
   Google Scholar
• EMEA Guidelines on the. Limits on Genotoxic Impurities. EMEA/CHMP/QWP/251344/2006, 2006.
   Google Scholar
• Kecili, R.; Billing, J.; Nivhede, D.; Sellergren, B.; Rees, A.; Yilmaz, E.J. (2014) Fast identification of selective resins for removal of genotoxic aminopyridine impurities via screening of molecularly imprinted polymer libraries. Journal of Chromatography. A, 1339: 65–72. doi:10.1016/j.chroma.2014.02.074
   PubMed Web of Science ®Google Scholar
• Wang, Y.; Sarris, K.; Sauer, D.R.; Djuric, S.W. (2007) An expeditious and convenient synthesis of acylsulfonamides utilizing polymer-supported reagents. Tetrahedron Letters, 48: 5181–5184. doi:10.1016/j.tetlet.2007.05.158
   Web of Science ®Google Scholar
• Lee, C.; Helmy, R.; Strulson, C.; Plewa, J.; Kolodziej, E.; Antonucci, V.; Mao, B.; Welch, C.J.; Ge, Z.; Al-Sayah, M.A. (2010) Removal of electrophilic potential genotoxic impurities using nucleophilic reactive resins. Organic Process Research & Development, 14: 1021–1026. doi:10.1021/op1000397
   Web of Science ®Google Scholar
• Kecili, R.; Billing, J.; Leeman, M.; Nivhede, D.; Sellergren, B.; Rees, A.; Yilmaz, E. (2013) Selective scavenging of the genotoxic impurity methyl p-toluenesulfonate from pharmaceutical formulations. Separation and Purification Technology, 103: 173–179. doi:10.1016/j.seppur.2012.09.028
   Web of Science ®Google Scholar
• Székely, G.; Fritz, E.; Bandarra, J.; Heggie, W.; Sellergren, B. (2012) Removal of potentially genotoxic acetamide and arylsulfonate impurities from crude drugs by molecular imprinting. Journal of Chromatography. A, 1240: 52–58. doi:10.1016/j.chroma.2012.03.092
   PubMed Web of Science ®Google Scholar
• Székely, G.; Bandarra, J.; Heggie, W.; Ferreira, F.C.; Sellergren, B. (2012) Design, preparation and characterization of novel molecularly imprinted polymers for removal of potentially genotoxic 1,3-diisopropylurea from API solutions. Separation and Purification Technology, 86: 190–198. doi:10.1016/j.seppur.2011.11.004
   Web of Science ®Google Scholar
• Chen, L.; Xu, S.; Li, J. (2011) Recent advances in molecular imprinting technology: current status, challenges and highlighted applications. Chemical Society Reviews, 40: 2922–2942. doi:10.1039/c0cs00084a
   PubMed Web of Science ®Google Scholar
• Esteves, T.; Viveiros, R.; Bandarra, J.; Heggie, W.; Casimiro, T.; Ferreira, F.C. (2016) Molecularly imprinted polymer strategies for removal of a genotoxic impurity, 4-dimethylaminopyridine, from an active pharmaceutical ingredient post-reaction stream. Separation and Purification Technology, 163: 206–214. doi:10.1016/j.seppur.2016.01.053
   Web of Science ®Google Scholar
• Takeuchi, T.; Minato, Y.; Takase, M.; Shinmori, H. (2005) Molecularly imprinted polymers with halogen bonding-based molecular recognition sites. Tetrahedron Letters, 46: 9025–9027. doi:10.1016/j.tetlet.2005.10.098
   Web of Science ®Google Scholar
• Vicente, A.I.; Esteves, T.; Afonso, C.A.M.; Ferreira, F.C. (2017) Solvent compatible polymer functionalization with adenine, a DNA base, for API degenotoxification: preparation and characterization. Separation and Purification Technology, 179: 438–448. doi:10.1016/j.seppur.2017.02.011
   Web of Science ®Google Scholar
• Székely, G.; Bandarra, J.; Heggie, W.; Sellergren, B.; Ferreira, F.C. (2011) Organic solvent nanofiltration: A platform for removal of genotoxins from active pharmaceutical ingredients. Journal of Membrane Science, 381: 21–33. doi:10.1016/j.memsci.2011.07.007
   Web of Science ®Google Scholar
• Székely, G.; Bandarra, J.; Heggie, W.; Sellergren, B.; Ferreira, F.C. (2012) A hybrid approach to reach stringent low genotoxic impurity contents in active pharmaceutical ingredients: combining molecularly imprinted polymers and organic solvent nanofiltration for removal of 1,3-diisopropylurea. Separation and Purification Technology, 86: 79–87. doi:10.1016/j.seppur.2011.10.023
   Web of Science ®Google Scholar
• Marchetti, P.; Solomon, M.F.J.; Szekely, G.; Livingston, A.G. (2014) Molecular separation with organic solvent nanofiltration: A critical review. Chemical Reviews, 114: 10735–10806. doi:10.1021/cr500006j
   PubMed Web of Science ®Google Scholar
• Székely, G.; Valtcheva, I.B.; Kim, J.F.; Livingston, A.G. (2015) Molecularly imprinted organic solvent nanofiltration membranes – revealing molecular recognition and solute rejection behaviour. Reactive and Functional Polymers, 86: 215–224. doi:10.1016/j.reactfunctpolym.2014.03.008
   Web of Science ®Google Scholar
• Bousquet, J.;. (2009) Mometasone furoate: an effective anti‐inflammatory with a well defined safety and tolerability profile in the treatment of asthma. International Journal of Clinical Practice, 63: 806–819. doi:10.1111/ijcp.2009.63.issue-5; b) Heggie, W.; Bandarra, J. Process for the preparation of mometasone furoate. US 6177560 B1, 2001.
   PubMed Web of Science ®Google Scholar
• Draper, R.W.; Hu, B.; McPhail, A.T.; Puar, M.S.; Vater, E.J.; Weber, L. (1999) Unusual hydroxy-γ-sultone byproducts of steroid 21-methanesulfonylation. An efficient synthesis of mometasone 17-furoate (Sch 32088). Tetrahedron, 55: 3355–3364. doi:10.1016/S0040-4020(98)01146-6
   Web of Science ®Google Scholar
• Sawatari, K.; Nakanishi, Y.; Matsushima, T. (2001) Relationships between chemical structures and mutagenicity: A preliminary survey for a database of mutagenicity test results of new work place chemicals. Industrial Health, 39: 341–345.
   PubMed Web of Science ®Google Scholar
• Müller, L.; Mauthe, R.J.; Riley, C.M.; Andino, M.M.; Antonis, D.; Beels, C.; DeGeorge, J.; De Knaep, A.G.M.; Ellison, D.; Fagerland, J.A.; Frank, R.; Fritschel, B.; Galloway, S.; Harpur, E.; Humfrey, C.D.N.; Jacks, A.S.; Jagota, N.; Mackinnom, J.; Mohan, G.; Ness, D.; O’Donovan, M.R.; Smith, M.; Vudathala, G.; Yotti, L. (2006) A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity. Regulatory Toxicology and Pharmacology : RTP, 44: 198–211. doi:10.1016/j.yrtph.2005.12.001
   PubMed Web of Science ®Google Scholar
• Snodin, D.J.;. (2010) Genotoxic impurities: from structural alerts to qualification. Organic Process Research & Development, 14: 960–976. doi:10.1021/op100118e
   Web of Science ®Google Scholar
• Zweifel, G.S.; Nantz, M.H.; Somfai, P. (2017) Modern Organic Synthesis: An Introduction, Hoboken: Wiley.
   Google Scholar
• Gerber, C.; Toelle, H. (2009) What happened: the chemistry side of the incident with EMS contamination in Viracept tablets. Toxicology Letters, 190: 248–253. doi:10.1016/j.toxlet.2009.02.020
   PubMed Web of Science ®Google Scholar
• Fu, X.; Kwok, D.-I.A.; Tann, C.-H.; Tsai, D.J.S. Process for the Preparation of 17-esters of 9α,21-dihalo-pregnane-11β,17αdiol-20-ones. WO1998000437 A1, 1998.
   Google Scholar
• Székely, G.; Gil, M.; Sellergren, B.; Heggie, W.; Ferreira, F.C. (2013) Environmental and economic analysis for selection and engineering sustainable API degenotoxification processes. Green Chemistry, 15: 210–225. doi:10.1039/C2GC36239B
   Web of Science ®Google Scholar
• Li, C.; Xu, M.; Sun, X.; Han, S.; Wu, X.; Liu, Y.-N.; Huang, J.; Deng, S. (2013) Chemical modification of Amberlite XAD-4 by carbonyl groups for phenol adsorption from wastewater. Chemical Engineering Journal, 229: 20–26. doi:10.1016/j.cej.2013.05.090
   Web of Science ®Google Scholar
• Belhachemi, M.; Addoun, F. (2011) Comparative adsorption isotherms and modeling of methylene blue onto activated carbons. Applied Water Science, 1: 111–117. doi:10.1007/s13201-011-0014-1
   Google Scholar
• Tosun, I.;. (2012) Ammonium removal from aqueous solutions by clinoptilolite: determination of isotherm and thermodynamic parameters and comparison of kinetics by the double exponential model and conventional kinetic models. International Journal of Environmental Research and Public Health, 9: 970–984. doi:10.3390/ijerph9030970
   PubMed Web of Science ®Google Scholar
• Qiu, H.; Lv, L.; Pan, B.-C.; Zhang, Q.-J.; Zhang, W.-M.; Zhang, Q.-X. (2009) Critical review in adsorption kinetic models. Journal of Zhejiang University. Science A, 10: 716–724. doi:10.1631/jzus.A0820524
   Web of Science ®Google Scholar
• Scudder, P.H.;. (2013) Electron Flow in Organic Chemistry: A Decision-Based Guide to Organic Mechanisms, Wiley: Hoboken, NJ.
   Google Scholar
• https://www.pharmacompass.com/active-pharmaceutical-ingredients/mometasone-furoate (assessed June 2018).
   Google Scholar